Terumo Corp. (OTCMKTS:TRUMY) Short Interest Down 54.4% in May

Terumo Corp. (OTCMKTS:TRUMY) was the recipient of a significant decrease in short interest during the month of May. As of May 15th, there was short interest totaling 14,067 shares, a decrease of 54.4% from the April 30th total of 30,823 shares. Based on an average daily trading volume, of 679,301 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the company’s stock are sold short.

Terumo Stock Down 3.6%

Shares of TRUMY stock traded down $0.52 on Tuesday, hitting $14.11. The stock had a trading volume of 222,924 shares, compared to its average volume of 254,931. The business has a 50 day moving average of $13.49 and a 200 day moving average of $13.87. The stock has a market cap of $20.81 billion, a price-to-earnings ratio of 23.13 and a beta of 0.67. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.51 and a quick ratio of 0.89. Terumo has a 12-month low of $12.08 and a 12-month high of $19.60.

Terumo (OTCMKTS:TRUMY) last announced its earnings results on Friday, May 15th. The company reported $0.11 EPS for the quarter, meeting the consensus estimate of $0.11. The company had revenue of $1.90 billion during the quarter, compared to the consensus estimate of $1.84 billion. Terumo had a net margin of 12.09% and a return on equity of 9.35%. As a group, analysts expect that Terumo will post 0.63 EPS for the current year.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. Zacks Research upgraded shares of Terumo to a “hold” rating in a report on Thursday, April 9th. Nomura upgraded shares of Terumo to a “hold” rating in a report on Tuesday, February 24th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock presently has a consensus rating of “Hold”.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.